例句與造句

1. A Phase II anti-tumor trial with Flt3 ligand is also underway in patients with prostate cancer and non-Hodgkin's lymphoma.
2. Later tests will investigate Flt3 ligand's ability to stimulate dendritic cells, which in turn could boost the immune system's ability to recognize cancer cells.
3. Immunex has completed two, Phase I Flt3 ligand safety trials and is currently in Phase II trials studying Flt3 ligand in combination with other compounds to boost immune response.
4. Immunex has completed two, Phase I Flt3 ligand safety trials and is currently in Phase II trials studying Flt3 ligand in combination with other compounds to boost immune response.
5. The company is also set to begin Phase I studies of a new product, called Flt3 ligand, a blood-cell growth factor that could speed cancer patients'recovery from chemotherapy.
6. It's difficult to find flt3 ligand in a sentence. 用flt3 ligand造句挺難的
7. Earlier this week it reported results of a Phase I human clinical study demonstrating that Flt3 ligand, one of its newest molecules, may be able to induce an immune response to cancer and infectious diseases.
8. Preclinical data, reported in the journal Nature Medicine on June 1, showed a dramatic increase in dendritic cells in mice treated with Flt3 ligand that resulted in tumor regression and anti-tumor immune responses.
9. The company said Phase I trials showed its Flt3 ligand immune system drug prompts the body to build about 30 times the normal number of dendritic cells, which play a key role in getting the immune system to respond to fight disease.
10. The data, presented at the 13th European Immunology Meeting in Amsterdam, showed Flt3 ligand caused a 30-fold increase in dendritic cells, which are a type of immune system cell that plays a role in initiating the immune response.
11. "The dramatic increase of dendritic cells induced by Flt3 ligand in this study and the relative ease of accessing these cells in the blood is very exciting, " said Doug Williams, Immunex's senior vice president of discovery research.